Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
Authors:
- A M VeitchAVA M Veitch
- British Society Of GastroenterologyBGBritish Society Of Gastroenterology
- British Committee for Standards in HaematologyBHBritish Committee for Standards in Haematology
- British Cardiovascular Intervention SocietyBSBritish Cardiovascular Intervention Society
Abstract
Please refer to fig 1 for an algorithmic representation of the recommendations, and tables 1–3 for a risk stratification of endoscopic procedures and medical conditions requiring anticoagulant or antiplatelet therapy. Aspirin therapy can be continued for all endoscopic procedures.Keywords
This publication has 61 references indexed in Scilit:
- A multicenter retrospective study of endoscopic resection for early gastric cancerGastric Cancer, 2006
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005
- Perioperative Management of Patients Receiving Oral AnticoagulantsArchives of internal medicine (1960), 2003
- Low‐molecular‐weight heparin for the treatment of patients with mechanical heart valvesClinical Cardiology, 2002
- Validation of Clinical Classification Schemes for Predicting StrokeJAMA, 2001
- A prospective analysis of 13,580 colonoscopiesSurgical Endoscopy, 2001
- Low-Molecular-Weight Heparin vs Heparin in the Treatment of Patients With Pulmonary EmbolismArchives of internal medicine (1960), 2000
- Postpolypectomy colonic hemorrhageDiseases of the Colon & Rectum, 1996
- Hemorrhage following colonoscopic polypectomyDiseases of the Colon & Rectum, 1993
- Discontinuing Anticoagulant Therapy in Surgical Patients With Cardiac Valve ProsthesesJAMA, 1978